Moneycontrol PRO
HomeNewsBusinessIPOSudeep Pharma shares settle 30% higher on debut day on NSE

Sudeep Pharma shares settle 30% higher on debut day on NSE

Sudeep Pharma shares made a strong stock market debut on both the NSE and BSE, outperforming grey market expectations.

November 28, 2025 / 16:12 IST
Sudeep Pharma shares listed on NSE, BSE on November 28. 
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Sudeep Pharma shares settled over 30 percent higher from its initial public offer (IPO) price on the debut day at Rs 771.85 per share on the National Stock Exchange (NSE) on Friday. The stock finished the first day trade 5.73 percent higher from its issue price.

    The shares of the company made a strong stock market debut to list at over 23 percent premium over its IPO price. The Rs 895-crore IPO had received a bumper subscription of 93.71 times between November 21-25 in the primary market.

    Shares of Sudeep Pharma Ltd were listed at Rs 730 per share on the National Stock Exchange (NSE), a decent premium of 23.10 percent. The price band for the offering was fixed at Rs 563-593 per equity share.

    On the BSE, the shares of the company were listed at Rs 725 apiece, a premium of 22.26 percent. The company's total market capitalization post listing of shares stood at Rs 8,188.78-crore.

    Sudeep Pharma share market debut was better than the expectations in the grey market, which had expected a premum listing of 20 percent. Earlier, it mobilised Rs 268.5 crore from anchor investors.

    Check All IPO News

    Proceeds from the fresh issue to the tune of Rs 75.81 crore will be used for capital expenditure toward the procurement of machinery for its production line located at the Nandesari Facility 1, Gujarat, and for general corporate purposes.

    Sudeep Pharma is a technology-led manufacturer of excipients and speciality ingredients for the pharmaceutical, food, and nutrition industries, dedicated to contributing to the global healthcare ecosystem.

    Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.

    Paras Bisht
    Paras Bisht A financial journalist with over 10 years of experience, specialising in tracking stock market movements and fundamental developments that impact investors and the broader economy. A keen observer of global financial markets, I regularly engage with leading market voices to write stories. At Moneycontrol, I focus on decoding market trends, policy shifts and economic changes, driven by a constant passion to learn, analyse, and share knowledge with my readers.
    first published: Nov 28, 2025 09:42 am

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347